Impressive developments at Utrecht Science Park Bilthoven
On Thursday 14 November, Utrecht Science Park Bilthoven opened its doors for a unique look behind the scenes. The Utrecht Science Park Café highlighted several impressive topics that are in full development in Bilthoven.
After a brief introduction by Jef de Clerq (CEO Poonawalla Science Park B.V.) and Jan Henk van der Velden ( managing director of the Utrecht Science Park), Jorrit van Hoorn (director of Corporate Development) took us through the latest developments of Utrecht Science Park Bilthoven.
Utrecht Science Park Bilthoven is home to Bilthoven Biologicals (BBio), a major producer of polio vaccines, among other things. BBio also has a crucial role to play in responding to a possible new pandemic. Over the past year, the Pandemic Preparedness Centre has been developed. This centre ensures that enough production capacity is available for vaccine production in possible future emergencies affecting public health.
RIVM, currently still housed in Bilthoven, is scheduled to move to the Utrecht Science Park during 2025. This offers new opportunities for both locations.
The interesting presentation was followed by a tour of Utrecht Science Park Bilthoven, past the special facilities.
Utrecht Science Park Bilthoven
Utrecht Science Park Bilthoven is one of the two satellite locations of the Utrecht Science Park. Bilthoven is home to companies and organisations in the fields of life sciences and sustainability. Utrecht Science Park Bilthoven specialises in product development, product improvement and manufacturing with a focus on vaccines.
GenDx and Treos Bio Announce Partnership to develop HLA-based Companion Diagnostic for PolyPEPI1018 Cancer Immunotherapy
GenDx, a Eurobio Scientific Company, based in the Netherlands, specialized in molecular diagnostics for transplantation, today announced a collaboration with Treos Bio, a UK based clinical stage
company, developing next generation of effective off-the-shelf peptide cancer immunotherapies. GenDx and Treos Bio will partner in the development and validation of an integrated companion
diagnostic (CDx) HLA-typing test for Treos Bio’s off-the-shelf peptide cancer immunotherapy candidate, PolyPEPI1018, for the treatment of microsatellite stable (MSS) colorectal cancer.
Alan Hanjalic new Dean Faculty of Science
From 1 July 2026, prof. dr. Alan Hanjalic has been appointed Dean of the Faculty of Science by the Executive Board of Utrecht University (UU). He will also be appointed professor at UU. Currently, Hanjalic is professor of Computer Science and head of the Intelligent Systems department at TU Delft.
Building energy independence at the Utrecht Science Park
At the Utrecht Science Park, five institutions are joining forces to develop a collective aquifer thermal energy storage system (ATES). With this initiative, they are taking an important step toward a future-proof, largely fossil-free energy system. A thermal source for heating and cooling is currently being installed to connect the first buildings. By 2030, several more buildings are expected to be linked to this shared infrastructure. By mutually sharing heat and cold, the campus will significantly reduce its reliance on natural gas and external energy sources.
UtrechtInc has been recognized in the Financial Times “Europe’s Leading Startup Hubs 2026” ranking.
While UtrechtInc is proud of this recognition, the real stars of the story are the entrepreneurs, researchers, and students who walk through its doors every day.